{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:09:19Z","timestamp":1787692159446,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajog.2024.03.012","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:18:40Z","timestamp":1710476320000},"page":"550.e1-550.e22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7332-1951","authenticated-orcid":false,"given":"Ane Cecilie","family":"Westerberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren-Helene Langeland","family":"Degnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina Jungersen","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Cecilie Paasche","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Melbye","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.03.012_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preghy.2012.11.001","article-title":"The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"3","author":"Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2024.03.012_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2024.03.012_bib3","doi-asserted-by":"crossref","first-page":"782.e1","DOI":"10.1016\/j.ajog.2016.07.056","article-title":"In\u00a0vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies","volume":"215","author":"Holme","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.012_bib4","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.3390\/ijms20174246","article-title":"Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors","volume":"20","author":"Tomimatsu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2024.03.012_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ajog.2024.03.012_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2024.03.012_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.03.012_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.placenta.2012.01.001","article-title":"Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia","volume":"33","author":"Paasche Roland","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2024.03.012_bib10","doi-asserted-by":"crossref","first-page":"H1381","DOI":"10.1152\/ajpheart.00922.2007","article-title":"Placental growth factor is a potent vasodilator of rat and human resistance arteries","volume":"294","author":"Osol","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajog.2024.03.012_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12916-022-02415-z","article-title":"Placenta-derived proteins across gestation in healthy pregnancies-a novel approach to assess placental function?","volume":"20","author":"Degnes","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.ajog.2024.03.012_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11010-021-04294-z","article-title":"The role of endoglin and its soluble form in pathogenesis of preeclampsia","volume":"477","author":"Margioula-Siarkou","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajog.2024.03.012_bib13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.03.012_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048259","article-title":"Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia","volume":"7","author":"Rana","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2024.03.012_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejogrb.2021.01.039","article-title":"Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis","volume":"258","author":"Margioula-Siarkou","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl","key":"10.1016\/j.ajog.2024.03.012_bib16","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.placenta.2013.10.020","article-title":"Review: the enigmatic role of endoglin in the placenta","volume":"35","author":"Gregory","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2024.03.012_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11906-018-0828-4","article-title":"The endothelin system: a critical player in the pathophysiology of preeclampsia","volume":"20","author":"Granger","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajog.2024.03.012_bib18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1570161111311050004","article-title":"Role of endothelin in uteroplacental circulation and fetal vascular function","volume":"11","author":"Paradis","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ajog.2024.03.012_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12079-020-00581-4","article-title":"A\u00a0network map of endothelin mediated signaling pathway","volume":"15","author":"Dagamajalu","year":"2021","journal-title":"J\u00a0Cell Commun Signal"},{"key":"10.1016\/j.ajog.2024.03.012_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rbmo.2012.07.014","article-title":"Endothelin-1: a key pathological factor in pre-eclampsia?","volume":"25","author":"Jain","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.03.012_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1753944715624853","article-title":"The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia","volume":"10","author":"Saleh","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2024.03.012_bib22","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/j.ydbio.2018.08.014","article-title":"News from the endothelin-3\/EDNRB signaling pathway: role during enteric nervous system development and involvement in neural crest-associated disorders","volume":"444","author":"Bondurand","year":"2018","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajog.2024.03.012_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","article-title":"Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia","volume":"122","author":"Staff","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.03.012_bib24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1542\/peds.2004-2240","article-title":"Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers","volume":"116","author":"Tsao","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.03.012_bib25","doi-asserted-by":"crossref","first-page":"176.e1","DOI":"10.1016\/j.ajog.2007.03.036","article-title":"Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia","volume":"197","author":"Staff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.012_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-0115(96)00122-X","article-title":"Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia","volume":"67","author":"Wolff","year":"1996","journal-title":"Regul Pept"},{"key":"10.1016\/j.ajog.2024.03.012_bib27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.ajog.2024.03.012_bib28","article-title":"The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology in\u00a0vivo","volume":"126","author":"Holme","year":"2017","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.ajog.2024.03.012_bib29","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1096\/fj.201801193R","article-title":"The human placental proteome secreted into the maternal and fetal\u00a0circulations in normal pregnancy based on\u00a04-vessel sampling","volume":"33","author":"Michelsen","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.ajog.2024.03.012_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117084","article-title":"Placental glucose transfer: a human in\u00a0vivo study","volume":"10","author":"Holme","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2024.03.012_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1210\/jc.2018-01154","article-title":"Uteroplacental glucose uptake and fetal glucose consumption: a quantitative study in human pregnancies","volume":"104","author":"Michelsen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.03.012_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185760","article-title":"Uptake and release of amino acids in the fetal-placental unit in human pregnancies","volume":"12","author":"Holm","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2024.03.012_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00726-018-2576-9","article-title":"Placental release of taurine to both the maternal and fetal circulations in human term pregnancies","volume":"50","author":"Holm","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.ajog.2024.03.012_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.placenta.2019.09.001","article-title":"Maternal-fetal cholesterol transfer in human term pregnancies","volume":"87","author":"Horne","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2024.03.012_bib35","first-page":"330","article-title":"ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists","volume":"66","author":"Schroeder","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajog.2024.03.012_bib36","series-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.ajog.2024.03.012_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10641950109152649","article-title":"Immunocytochemical localization of endothelin-1 in human placenta from normal and preeclamptic pregnancies","volume":"20","author":"Barros","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2024.03.012_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02913732","article-title":"Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta","volume":"271","author":"Malassin\u00e9","year":"1993","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ajog.2024.03.012_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.109.141473","article-title":"Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats","volume":"55","author":"Murphy","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/HYPERTENSIONAHA.115.05267","article-title":"Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression","volume":"65","author":"Verdonk","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.117.10849","article-title":"Causative effects of genetically determined high maternal\/fetal endothelin-1 on preeclampsia-like conditions in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.37.2.485","article-title":"Endothelin Type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure","volume":"37","author":"Alexander","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.119.14183","article-title":"Transfer and vascular effect of endothelin receptor antagonists in the human placenta","volume":"75","author":"Hitzerd","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004040050238","article-title":"Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome","volume":"262","author":"Bussen","year":"1999","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.03.012_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.012_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/HYPERTENSIONAHA.122.19078","article-title":"Vascular disorders of pregnancy increase susceptibility to neonatal pulmonary hypertension in high-altitude populations","volume":"79","author":"Heath-Freudenthal","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib47","first-page":"61","article-title":"Maternal and umbilical venous levels of endothelin in women with pre-eclampsia","volume":"6","author":"Tsunoda","year":"1992","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.ajog.2024.03.012_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(95)90079-9","article-title":"Fetal and maternal plasma endothelin levels during the second half of pregnancy","volume":"172","author":"Radunovic","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.012_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/14767058.2017.1401996","article-title":"How does preeclampsia affect neonates? Highlights in the disease\u2019s immunity","volume":"32","author":"Marins","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2024.03.012_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/y03-013","article-title":"Endothelin in the perinatal circulation","volume":"81","author":"Perreault","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ajog.2024.03.012_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total versus free placental\u00a0growth factor levels in the pathogenesis of preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2024.03.012_bib52","doi-asserted-by":"crossref","first-page":"569.e1","DOI":"10.1016\/j.ajog.2022.11.001","article-title":"Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood","volume":"228","author":"Chaiworapongsa","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.012_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590.2016.1241228","article-title":"Lower placental growth factor and higher free \u03b2-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia","volume":"33","author":"Paredes","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.03.012_bib54","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2024.03.012_bib55","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/acs.jproteome.2c00391","article-title":"Human plasma proteome during normal pregnancy","volume":"21","author":"Tarca","year":"2022","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.ajog.2024.03.012_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202100170","article-title":"Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms","volume":"22","author":"Haslam","year":"2022","journal-title":"Proteomics"},{"key":"10.1016\/j.ajog.2024.03.012_bib57","article-title":"Early prediction and longitudinal modeling of preeclampsia from multiomics","volume":"3","author":"Mari\u0107","year":"2022","journal-title":"Patterns (N Y)"},{"key":"10.1016\/j.ajog.2024.03.012_bib58","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ajh.2011.99","article-title":"Endothelin: key mediator of hypertension in preeclampsia","volume":"24","author":"George","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2024.03.012_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22116-0","article-title":"Assessment of variability in the plasma 7k SomaScan proteomics assay","volume":"12","author":"Candia","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.03.012_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900278","article-title":"Comparison of proteomic assessment methods in multiple cohort studies","volume":"20","author":"Raffield","year":"2020","journal-title":"Proteomics"},{"issue":"Suppl2","key":"10.1016\/j.ajog.2024.03.012_bib61","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/j.placenta.2010.12.012","article-title":"Review: water channel proteins in the human placenta and fetal membranes","volume":"32","author":"Damiano","year":"2011","journal-title":"Placenta"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824004411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824004411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:16:03Z","timestamp":1736439363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824004411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0002937824004411"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.012","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}